Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-19
2010-02-09
Kwon, Brian-Yong S (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S176000, C546S184000
Reexamination Certificate
active
07659286
ABSTRACT:
N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, pharmaceutically acceptable salts thereof, and/or mixtures thereof, as well as, pharmaceutical compositions thereof, methods of treatment therewith, and processes of making N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide and intermediates thereof.
REFERENCES:
patent: 2898339 (1959-08-01), Wheeler et al.
patent: 4581171 (1986-04-01), Kennis et al.
patent: 6187792 (2001-02-01), Delorme et al.
patent: 6455545 (2002-09-01), Delorme et al.
patent: 6552036 (2003-04-01), Boyd et al.
patent: 6693117 (2004-02-01), Delorme et al.
patent: 6753335 (2004-06-01), Brown et al.
patent: 6784181 (2004-08-01), Brown et al.
patent: 6838468 (2005-01-01), Brown et al.
patent: 7312336 (2007-12-01), Delorme et al.
patent: 2001/0029258 (2001-10-01), Snutch
patent: 2004/0204404 (2004-10-01), Zelle et al.
patent: 2006/0287361 (2006-12-01), Brown et al.
patent: 2007/0066652 (2007-03-01), Brown et al.
patent: 2007/0099957 (2007-05-01), Brown et al.
patent: 9828275 (1998-07-01), None
patent: 9933806 (1999-07-01), None
patent: 0145637 (2001-06-01), None
patent: 0146166 (2001-06-01), None
patent: 0174806 (2001-10-01), None
patent: 02094811 (2002-11-01), None
patent: 2004100952 (2004-11-01), None
patent: WO 2004/101522 (2004-11-01), None
patent: 2005087742 (2005-09-01), None
patent: 2008048171 (2008-04-01), None
Wei et al., “N,N-Diethyl-4-)phenylpiperidin-4-ylidenemethyl) benzamide: A Novel, Exceptionally Selective, Potent gamma Opioid Receptor Agonist with Oral Bioavailability and It's Analogues,” J. Med. Chem., 2000, vol. 43, pp. 3895-3905.
Zhang et al., “Probes for Narcotic Receptor Mediated Phenomena. 26. 1-3 Synthesis and Biological Evaluation of Diarylmethylpiperidines as Novel, Nonpeptidic Opioid Receptor Ligands,” J. Med. Chem., 1999, vol. 42, pp. 5455-5463.
International Search Report issued for PCT/SE2007/000924 on Jan. 8, 2008.
Co-pending U.S. Appl. No. 11/951,014, filed Dec. 5, 2007.
Brandt et al., “Antinociceptive Effects of Delta-Opioid Agonists in Rhesus Monkeys: Effects on Chemically Induced Thermal Hypersensitivity,” The Journal of Pharmacology and Experimental Therapeutics, 2001, vol. 296, No. 3, pp. 939-946.
Bilsky et al., “Characterization of Enantiomers of (+−)BW373U86 and Related Compounds: Highly Selective Non-Peptidic Delta Opioid Agonists,” Reg. Peptides, 1994, vol. 54, pp. 25-26.
Bilsky et al., “SNC 80, A Selective, Nonpeptidic and Systemically Active Opioid Delta Agonist,” J. Pharm. Exper. Ther., 1995, vol. 273, pp. 359-366.
Carson et al., “N,N-Dialkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene) phenylmethyl]- benzamides, potent, selective opioid agonists,” Bioorganic & Medicinal Chemistry Letters, 2004, vol. 14, pp. 2109-2112.
Plobeck et al., “New Diarylmethylpiperazines as Potent and Selective Nonpeptidic Opioid Receptor Agonists with Increased In Vitro Metabolic Stability,” J. Med. Chem., 2000, vol. 43, pp. 3878-3894.
Non-Final OA issued for U.S. Appl. No. 10/240,114 (now USP 6753335) on Sep. 25, 2003.
Co-Pending U.S. Appl. No. 12/445,883, filed Apr. 16, 2009.
Dantzman Cathy
Ernst Glen
King Megan Murphy
AstraZeneca AB
Baek Bong-Sook
Cohen Jacqueline M.
Kwon Brian-Yong S
LandOfFree
N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-yl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-yl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-yl... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4168358